
iCAD ICAD
Quarterly report 2025-Q1
added 05-13-2025
iCAD Cash Conversion Cycle 2011-2025 | ICAD
Annual Cash Conversion Cycle iCAD
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117 | 187 | 257 | 135 | 142 | 6.75 | -20.6 | 46.9 | 66.4 | 102 | 36.3 | 43.2 | 48.8 | 44.3 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 257 | -20.6 | 86.6 |
Quarterly Cash Conversion Cycle iCAD
| 2025-Q1 | 2024-Q4 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76.4 | - | 130 | - | - | 520 | 306 | - | 272 | 230 | 188 | - | 154 | 188 | 139 | - | 140 | 185 | 158 | 86.7 | 117 | 123 | 124 | 81.2 | 118 | 128 | 144 | 99.3 | 142 | 159 | 156 | 68.3 | 182 | 182 | 216 | 89.8 | 161 | 137 | 92 | 66.8 | 36.7 | 47.5 | 91.6 | 76.2 | 79.7 | 86.2 | 73.9 | 58.1 | 62.6 | 85.9 | 88.9 | 55.3 | 84 | 93.9 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 520 | 36.7 | 133 |
Cash Conversion Cycle of other stocks in the Health information services industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cerner Corporation
CERN
|
-20 | - | - | $ 27.9 B | ||
|
Computer Programs and Systems
CPSI
|
43.2 | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
52.1 | - | - | $ 2.94 B | ||
|
Accolade
ACCD
|
-4.64 | - | 0.29 % | $ 206 M | ||
|
Castlight Health, Inc.
CSLT
|
68.7 | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
-587 | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
56.1 | - | - | $ 6.37 B | ||
|
Change Healthcare
CHNG
|
87 | - | - | $ 9.03 B | ||
|
Evolent Health
EVH
|
183 | $ 4.07 | 3.17 % | $ 381 M | ||
|
Health Catalyst
HCAT
|
50 | $ 2.45 | -4.3 % | $ 147 M | ||
|
HealthStream
HSTM
|
14.1 | $ 24.19 | -0.62 % | $ 735 M | ||
|
Akerna Corp.
KERN
|
-89.4 | - | - | $ 161 M | ||
|
HealthEquity
HQY
|
92.5 | $ 97.98 | 0.61 % | $ 8.38 B | ||
|
American Well Corporation
AMWL
|
90 | $ 4.51 | 3.2 % | $ 67.6 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
71 | - | -10.39 % | $ 886 M | ||
|
MTBC
MTBC
|
40.6 | - | -0.58 % | $ 51.7 M | ||
|
GoodRx Holdings
GDRX
|
-124 | $ 2.84 | 1.79 % | $ 1.1 B | ||
|
Omnicell
OMCL
|
112 | $ 43.75 | 1.05 % | $ 2.01 B | ||
|
1Life Healthcare
ONEM
|
39.8 | - | - | $ 3.37 B | ||
|
OptimizeRx Corporation
OPRX
|
125 | $ 13.45 | -4.13 % | $ 230 M | ||
|
Progyny
PGNY
|
121 | $ 26.65 | 2.46 % | $ 2.29 B | ||
|
Phreesia
PHR
|
1.78 | $ 16.16 | 0.75 % | $ 882 M | ||
|
Premier
PINC
|
110 | $ 28.26 | - | $ 2.33 B | ||
|
Signify Health
SGFY
|
214 | - | -0.02 % | $ 7.21 B | ||
|
R1 RCM
RCM
|
21.9 | - | - | $ 3.81 B | ||
|
So-Young International
SY
|
87 | $ 3.06 | -1.61 % | $ 243 M | ||
|
NantHealth
NH
|
-54.1 | - | -46.64 % | $ 10.4 M | ||
|
NextGen Healthcare
NXGN
|
37.1 | - | - | $ 1.6 B | ||
|
Schrödinger
SDGR
|
199 | $ 18.05 | -0.44 % | $ 1.31 B | ||
|
Zhongchao
ZCMD
|
-1.06 | $ 0.62 | 0.6 % | $ 3.23 M | ||
|
Streamline Health Solutions
STRM
|
59.4 | - | - | $ 21.4 M | ||
|
Teladoc Health
TDOC
|
28.4 | $ 7.58 | -0.59 % | $ 1.29 B | ||
|
10x Genomics
TXG
|
167 | $ 15.57 | -5.86 % | $ 1.82 B | ||
|
Tabula Rasa HealthCare
TRHC
|
12 | - | - | $ 255 M | ||
|
Veeva Systems
VEEV
|
100 | $ 223.05 | -2.81 % | $ 35.8 B | ||
|
SCWorx Corp.
WORX
|
41.4 | $ 0.21 | -3.41 % | $ 306 K |